HSV vector expressing full length tyrosinase, gp100 and MART-1optimised for antigen delivery to dendritic cells by the deletion of HSV genes which usually inhibit DC function. These deliver antigens to DC at very high efficiency and activate the transduced cells similarly to LPS. Biovex provides the possibility of using these vectors for a variety of pre-clinical, and ultimately clinical studies.

Expression vectors for GFP-RIG-I used to analyse the interaction between RIG-I, a viral sensing protein, and NS1, an inhibitor of interferon production that is encoded by influenza A virus have been made available.